A Medigene platform · Omnichannel HCP engagement

One knowledge network for everyone in the care chain

A prescription travels from the doctor who writes it, to the pharmacist who dispenses it, with a field representative connecting both. MedShorts gives all three the same accurate, bite-sized science, through one personalised link they can open on any phone.

Who MedShorts servesProgrammes for pharma

The MedShorts network

DoctorsClinical updates in five minutes or less
PharmacistsDispensing, counselling and safety capsules
Field forceProduct knowledge, certification and shareable links
One dashboardReach, engagement and learning, by audience
MedShorts 360 · Latest

Latest news, 17 November 2026

One new story for each specialty, every morning: short, sourced and readable between patients.

CardiologyCardiology

Lp(a) HORIZON: pelacarsen lowers lipoprotein(a) but does not reduce cardiovascular events

In over 8,000 patients with cardiovascular disease and high Lp(a), monthly pelacarsen cut Lp(a) sharply but did not lower major adverse cardiovascular events versus placebo over a median 4.7 years, NEJM reports.

Medical Dialogues
DiabetologyDiabetology

WHO issues its first guidelines on diagnosing and managing type 1 diabetes in adults

Released for World Diabetes Day 2026, the WHO guidelines call for multiple daily insulin injections, accept human insulin as effective, and recommend regular glucose monitoring, with urine testing where blood tests are unavailable.

Medical Dialogues
NephrologyNephrology

Prepare for Kidney Care trial: conservative care matches dialysis preparation in frail older adults

In a UK trial of 445 older adults with kidney failure and frailty or multimorbidity, preparing for dialysis did not give better combined length and quality of life than a structured non-dialysis pathway, The Lancet reports.

Medical Dialogues
NeurologyNeurology

Rituximab linked to higher risk of new-onset IBD than other MS therapies in Swedish registry study

Among Swedish adults with relapsing-remitting MS, rituximab was associated with an IBD incidence of 110 per 100,000 person-years versus 13 with natalizumab, dimethyl fumarate or fingolimod, JAMA Neurology reports.

Medical Dialogues
UrologyUrology

US FDA approves perioperative durvalumab plus enfortumab vedotin for cisplatin-ineligible MIBC

Based on the phase 3 VOLGA trial, the FDA approved neoadjuvant durvalumab plus enfortumab vedotin followed by adjuvant durvalumab after cystectomy for muscle-invasive bladder cancer in patients unable or unwilling to take cisplatin.

Urology Times
PsychiatryPsychiatry

Cannabis use linked to about twice the risk of violence in a 63-study meta-analysis

A King's College London meta-analysis of 63 studies and more than 265,000 people links cannabis use with higher odds of committing and experiencing violence, especially among people in psychiatric care.

Medical Dialogues
PulmonologyPulmonology

Indian review urges looking beyond the AHI to hypoxic burden and arousals in sleep apnoea

A narrative review from RML Institute, Lucknow, argues that hypoxic burden, oxygen desaturation index, arousal index and pulse transit time may predict cardiovascular risk in obstructive sleep apnoea better than the apnoea-hypopnoea index alone.

Medical Dialogues
Critical CareCritical Care

Antibiotic delay beyond one hour tied to higher sepsis deaths only with hypotension or lactate of 4 or more

In 1.85 million US encounters with suspected infection, giving antibiotics at 1-3 hours rather than within 1 hour was linked to higher in-hospital mortality only when sepsis time zero was set by hypotension or lactate of 4.0 mmol/L or more.

American Journal of Respiratory and Critical Care Medicine
GastroenterologyGastroenterology

Indian review: coeliac disease affects nearly 1% in north India, yet many children go undiagnosed

A review in Apollo Medicine notes coeliac disease prevalence approaching 1% in north Indian states, often presenting in children only as iron-deficiency anaemia or short stature, and outlines testing and diet advice for Indian practice.

Medical Dialogues
DermatologyDermatology

Adding 5% topical caffeine to fluocinolone cream improved plaque psoriasis in a small four-week RCT

In a 40-patient randomised trial from Iran, 5% caffeine added to 0.025% fluocinolone acetonide cream gave larger PASI reductions and more complete clearance at four weeks than the steroid alone, with no adverse effects reported.

Medical Dialogues
OphthalmologyOphthalmology

After posterior capsule rupture, sulcus IOLs gave better vision and fewer complications than AC-IOLs

In 249 eyes with posterior capsule rupture and vitreous loss at an Israeli tertiary centre, three-piece sulcus lenses gave greater visual gain at six months than anterior chamber or iris-fixated lenses, with fewer vision-threatening complications than anterior chamber lenses.

International Ophthalmology
ENTENT

Intracapsular tonsillectomy linked to fewer bleeds needing treatment in adults: meta-analysis of four RCTs

Pooling four randomised trials with 370 patients aged 16 or older, intracapsular tonsillectomy was associated with a lower risk of post-tonsillectomy haemorrhage needing medical intervention than extracapsular surgery (2.0% vs 11.4%; risk ratio 0.23).

European Archives of Oto-Rhino-Laryngology
OrthopaedicsOrthopaedics

HARD trial: first MTP joint fusion eases walking pain in hallux rigidus better than watchful waiting

In a Finnish randomised trial of 90 adults aged 40 or older with symptomatic hallux rigidus, first metatarsophalangeal joint arthrodesis cut walking pain far more than watchful waiting at 12 months, with no serious adverse events.

Healio
GynaecologyGynaecology

Cancer survivors face higher severe maternal morbidity at delivery in US nationwide study

In over 28 million US hospital deliveries, women with a past cancer history had 45% higher and those with current cancer nearly four times higher severe maternal morbidity than women without cancer.

JAMA Network Open
PaediatricsPaediatrics

ADHD classroom trial: methylphenidate and behaviour therapy help, academic accommodations do not

In a crossover trial of 255 school-age children with ADHD, extended-release methylphenidate and behaviour therapy improved classroom behaviour, but extra time, breaks and low-distraction seating gave no benefit.

JAMA Pediatrics
SurgerySurgery

PGIMER study: infants with temporary ileostomies remain malnourished and anaemic six months after surgery

A prospective PGIMER Chandigarh study of 50 infants with ileostomies found persistent severe underweight, hypoproteinaemia, anaemia and micronutrient deficits at six months compared with surgical controls.

Medical Dialogues
General MedicineGeneral Medicine

Denosumab linked to fewer refractures than bisphosphonates after fragility fracture, with similar mortality

In an Australian cohort of over 15,000 adults aged 50 and above starting treatment after a low-trauma fracture, bisphosphonates were linked to 14-21% higher refracture risk than denosumab, with no difference in deaths.

JAMA Network Open
17 new today · 17 latest storiesSee all MedShorts 360 stories →
Get the MedShorts app

Add MedShorts to your phone's home screen: today's stories in one tap, full screen, no app store needed.

Why MedShorts is changing

Medical communication has outgrown the single doctor visit

Indian pharma has traditionally put almost all of its scientific effort into one moment: the representative's few minutes with a doctor. Yet outcomes depend on much more than that moment. The pharmacist decides how a medicine is explained, substituted and taken. The representative's own confidence in the science shapes every conversation. And the doctor, seeing dozens of patients a day, needs updates that fit between consultations, not another hour-long webinar.

MedShorts began as a smart way to send doctors a personalised content library through a single link. We are now extending it into a broader strategic initiative: a knowledge network that serves the doctor, the pharmacist and the field force together, with consistent science, the right depth for each role, and one view of engagement for the brand team.

The result is fewer disconnected campaigns and more joined-up education, where the doctor's prescription, the pharmacist's counselling and the representative's message all say the same thing.

What changes with MedShorts

01
From one audience to threeContent written separately for prescribers, dispensers and representatives, from the same evidence base.
02
From campaigns to a programmeA planned calendar of short updates across the year instead of one-off mailers.
03
From clicks to insightEngagement data by specialty, geography and audience, fed back into the next cycle.
04
From information to learningQuizzes, certification and links to Medigene CME where a deeper course exists.
Who MedShorts serves

Built for three roles that shape every treatment

Each audience gets its own experience, written for how they work and what they need to decide, while the science underneath stays the same.

For doctors

Clinical knowledge between consultations

Short clinical updates, guideline summaries, journal digests and KOL perspectives, curated by specialty and delivered to the phone.

  • Read or watch in under five minutes
  • Specialty-specific libraries
  • Patient education material to share
MedShorts for doctors →
For pharmacists

Confident counselling at the counter

Practical capsules on dosing, interactions, storage, adherence and safety, written for community and hospital pharmacists.

  • Counselling scripts and checklists
  • Drug interaction and safety alerts
  • Available in English and Hindi
MedShorts for pharmacists →
For field force

Scientific confidence in every call

Micro-learning on disease, molecule and evidence, with assessments, certification and approved links representatives can share with doctors.

  • Daily five-minute learning bursts
  • Quizzes and product certification
  • Compliant, trackable sharing
MedShorts for field force →
The connected care chain

One message, from the representative to the patient

When all three roles learn from the same source, the patient hears one consistent story about their treatment.

Field representative

Learns the evidence, passes certification, shares an approved MedShorts link.

Doctor

Reviews the update in minutes, prescribes with the latest guidance, shares patient material.

Pharmacist

Dispenses correctly and counsels on dose, timing, side-effects and adherence.

MedShorts hubShared evidence base, medical review, multi-language content and one analytics layer across all three audiences.See the programme model
Strategic pillars

Five things MedShorts is built on

Short, evidence-led content

Every piece is written from published evidence and guidelines, reviewed by our medical team and kept to the length a busy clinician will actually finish.

Reach where people already are

Personalised links by SMS, email and WhatsApp, QR codes at pharmacies and clinics, and representative-shared links. No app to download.

Learning, not just reading

Quizzes, case challenges and certification turn content into measurable learning, with deeper courses on Medigene Learn.

Insight for brand teams

Open, read-through, video-completion and quiz data by audience, specialty and region, reported in one dashboard.

Trust and compliance

Medical and regulatory review, content aligned with the approved prescribing information, consent-based contact and data handled under India's data-protection law.

India-first delivery

Designed for low-bandwidth mobile use, with English and Hindi as standard and regional languages for pharmacist and patient material.

How it works

Receive, open, learn, act

Receive

A personalised MedShorts link arrives by SMS, email or WhatsApp, or is shared by a representative.

Open

One tap opens a secure, mobile-friendly library. A one-time registration keeps it personal.

Learn

Short articles, videos, infographics and quizzes, chosen for the reader's role and specialty.

Act

Apply it in practice, share patient material, or continue to a full CME course.

Measure

Engagement flows into the brand dashboard and shapes the next content cycle.

Content formats

The right format for every minute available

Clinical shorts

Two-to-three-minute reads on a single clinical question.

KOL video bites

Expert perspectives in three-to-five-minute clips.

Journal digests

Landmark and recent trials summarised with key numbers.

Guideline snapshots

What changed, and what it means in clinic.

Quizzes & case challenges

Test and reinforce, with instant explanations.

Patient education

Leaflets and videos doctors and pharmacists can share.

Interactive tools

Lung-sound and ECG trainers, calculators and checklists.

Safety alerts

Interaction, storage and pharmacovigilance reminders.

Already live

A growing library across specialties

MedShorts already hosts series in neurology, cardio-metabolic care, respiratory medicine, orthopaedics, oncology, women's health, critical care, dermatology, dentistry and ophthalmology, including interactive trainers for lung sounds and ECG interpretation.

The new network brings these together in one library and adds dedicated tracks for pharmacists and field teams.

NeurologyCardio-metabolicRespiratoryOrthopaedicsOncologyWomen's healthCritical careDermatologyDentalOphthalmology

Browse the content library

Fewer, shorter and better-targeted messages, shared by everyone around the patient, do more than any single detailing call.The idea behind the MedShorts network

Bring your brand science to the whole care chain

Talk to us about a MedShorts programme that reaches your doctors, their pharmacists and your field force with one consistent, compliant message.

Talk to our team